A nationwide survey of Japanese public perceptions of the necessity of antemortem informed consent for Rapid Autopsy Programs (RAP): comparison with other methods of postmortem human tissue utilization Authors: Yuki Fujiwara, Go Okui, Masanori Oikawa, Mia Miyanaga Published: 2026 ABSTRACT BackgroundRapid Autopsy Programs (RAP) are essential research infrastructures for precision medicine, providing high-quality biospecimens. While international standards emphasize the importance of antemortem informed consent, Japan’s ethical and legal frameworks for RAP remain underdeveloped. Currently, Japan lacks a consistent approach to postmortem tissue utilization, with requirements for individual consent varying significantly between pathological autopsies, systematic dissection, and organ transplantation. This study aims to clarify Japanese public perceptions regarding the necessity of antemortem consent for RAP in comparison with these established methods to inform the development of future ethical guidelines.MethodsA nationwide internet survey was conducted in January 2025, involving 3,102 participants representative of the Japanese population’s sex, age, and regional distribution. Participants viewed an educational video explaining four methods of postmortem tissue utilization: pathological autopsy, RAP, systematic dissection, and organ transplantation. To prevent bias, actual names and current legal statuses were not disclosed. Respondents rated the necessity of antemortem individual consent for each method using a six-point Likert scale. Statistical analyses were performed to identify differences between methods and demographic influences.ResultsThe survey revealed a strong public preference for antemortem consent across all methods. Specifically, over 70% of respondents agreed that antemortem consent is necessary for pathological autopsies, and over 85% expressed the same view for RAP, systematic dissection, and organ transplantation. The results showed a marked discrepancy between Japan’s current legal system—which often relies on family consent—and public ethical awareness emphasizing individual will. While 90% valued antemortem consent for respecting individual wishes, over 50% acknowledged the difficulty of refusing a physician’s request and emphasized the importance of family intentions. Women and older adults placed significantly greater importance on antemortem consent for RAP.ConclusionsThe Japanese public maintains high expectations for individual antemortem consent that exceed current legal requirements for some procedures. However, the findings also highlight the role of “relational autonomy,” where family involvement and the clinical-research power dynamic influence decision-making. Developing an ethical framework for RAP in Japan requires not only prioritizing individual autonomy but also implementing “supported decision-making” and a clear separation between clinical and research teams to ensure social trust and cultural compatibility.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12910-026-01465-9. Background Rapid Autopsy refers to a postmortem examination conducted within several hours after a patient’s death, during which tumor and normal tissues are collected from multiple sites for research purposes [1]. This approach allows for the acquisition of samples that preserve the high-quality biomolecules such as RNA and DNA, thereby providing crucial insights into cancer treatment resistance, the identification of novel biomarkers, and the evaluation of drug responsiveness [2, 3]. The Rapid Autopsy Program (RAP) is an institutionalized framework designed to systematically implement rapid autopsies. It enables timely postmortem examinations of patients with cancer or other diseases and facilitates the collection of tumor and non-tumor tissues from multiple anatomical sites [4]1. Through the provision of high-quality biospecimens obtained from rapid autopsies, RAP has been recognized as an important research infrastructure contributing to the realization of precision medicine, an approach that identifies the most effective treatments or preventive strategies for specific groups of patients based on their genetic, environmental, and lifestyle factors [5]. A fundamental framework for discussing the ethical challenges of postmortem human tissue utilization—including autopsy, body donation, and organ donation—is the four principles of biomedical ethics derived from common morality: respect for autonomy, nonmaleficence, beneficence, and justice [6–9]. These four principles are integrated into various processes of medical care and research [8], and their application to postmortem tissue utilization has been extensively debated. For instance, in forensic or administrative autopsies, the pursuit of justice often takes precedence over respect for autonomy [10, 11]. Furthermore, invasive procedures on a deceased body may lead to a conflict between the principles of justice and nonmaleficence, as the perception of harm to the deceased is deeply contingent upon cultural or religious values [10]. In the context of body donation for medical education, respect for autonomy is considered an absolute requirement, necessitated by signed informed consent based on the donor’s free will [12, 13]. This is particularly salient in body donation following Physician-Assisted Dying, where ensuring nonmaleficence and respect for autonomy requires a complete separation between the dying process and donation procedures to eliminate unsolicited solicitation [13]. In organ donation, while the principle of nonmaleficence remains fundamental, consent models such as opt-in and opt-out have been debated as a means to ensure respect for autonomy [14]. Furthermore, recent scholarship has emphasized the importance of “relational autonomy,” which considers the individual’s environmental and social context [15–19]. Especially in situations involving cognitive impairment or emotional distress, decision-making is increasingly viewed not as an isolated exercise of will but as a relational, ongoing process involving family members and professionals [18]. Thus, while respect for autonomy remains the cornerstone of the consent process for postmortem tissue and body donation, its implementation continues to be discussed in the context of potential conflicts with the other three principles. RAP, in particular, presents three distinct ethical challenges: (1) temporal constraints [20, 21], (2) the lack of direct benefit to the donor [20], and (3) a primary focus on the principle of beneficence directed toward society [22, 23]. These characteristics suggest that the potential conflicts between ethical principles in RAP may operate through mechanisms different from those previously discussed in other forms of postmortem human tissue utilization. In countries where RAPs have already been established, clinical practice and operational processes have been implemented in alignment with the aforementioned ethical principles governing the utilization of postmortem human tissue. Specifically, implementing RAP requires not only rapid postmortem response but also obtaining consent from bereaved families and establishing procedures for obtaining the patient’s antemortem consent, along with operational protocols [20]. In many RAPs, written informed consent is obtained in advance from patients or their next of kin, and detailed guidelines and standardized operating procedures have been reported to systematize these consent processes [21]. The National Cancer Institute’s “Biospecimen Best Practices” recommends the use of standardized consent templates, documentation of consent procedures, and approval by ethics review boards. These practices emphasize the importance of developing well-defined collection protocols for research biospecimens, including—but not limited to—RAP and postmortem tissue donations [24]. The importance of antemortem consent and specific procedural guidelines are well established in major RAPs and cancer centers in the United States [24–26]. Similarly, the Human Tissue Authority (HTA) in the United Kingdom stipulates that consent from the individual donor takes precedence and that the expressed will of the donor must be respected to the greatest possible extent [27]. However, in some U.S. states, rapid autopsies may proceed based solely on the consent of legal next of kin after the patient’s death [22], and institutions such as the Research Autopsy Center at Stanford and Johns Hopkins explicitly state that procedures can be conducted with next-of-kin consent alone when the patient is unable to provide written consent [28, 29]. Thus, although RAP is ideally predicated on the donor’s antemortem consent, operational systems are designed to accommodate situations where such consent is unavailable. The above summarizes the consent frameworks in countries where RAPs are already established. In contrast, in Japan, the institutional and ethical framework for RAP remains underdeveloped, and public understanding is still limited. Before describing Japan’s situation, it is necessary to outline the three major types of postmortem human tissue utilization currently practiced in Japan. The first is pathological autopsy, which is conducted primarily for determining the cause of death or evaluating treatment effects. In Japan, this is typically performed with only the consent of the bereaved family [30, 31]. The second is systematic dissection, referring to cadaver dissections performed for medical and dental education. These are conducted based on the deceased’s antemortem declaration of intent (body donation registration), with confirmation from the bereaved family after death [32]. The third is organ transplantation, in which functional organs from a deceased donor are transplanted into recipients for life-saving purposes. This requires that the individual did not refuse donation during life and that family consent is obtained [33]. In Japan, aside from the Akita Rapid Autopsy Program (ARAP) introduced by Akita University in 2021 [21]—a pilot conducted in conjunction with pathological autopsies—RAP has not yet been implemented on a full scale. Its ethical framework remains unestablished, and public awareness is insufficient. Notably, under Japan’s Act on Postmortem Examination and Corpse Preservation (Act No. 204 of 1949), pathological autopsies are conducted without requiring the patient’s antemortem consent, relying solely on family consent [30, 31]. From the perspective of the four principles of biomedical ethics, the current Japanese legal framework prioritizes the principle of beneficence—aimed at improving public health—over the respect for the donor’s autonomy, leaving significant room for ethical debate. This contrasts with international practices recommending antemortem consent for RAP, as well as Japan’s systematic dissection requiring the donor’s consent and organ transplantation based on the donor’s consent. From the perspective of ethical consistency regarding postmortem use of the human body, this discrepancy presents a significant challenge. At the same time, individual decision-making and the expression of intent are profoundly influenced by the socio-cultural context of each nation. Given that non-Western cultures often place a greater emphasis on interpersonal relationships alongside the individual [15], it is necessary to examine models of antemortem consent and respect for autonomy that encompass these relational dynamics. Against this background, the present study focuses on the proactive expression of intent (opt-in). We define “antemortem consent” as a declaration made by a patient or a member of the general public, at a point when they are capable of deliberate judgment, stating that “after my death, my body may be used for specific or various types of medical research and healthcare.” The aforementioned institutional imbalances not only hinder the widespread implementation of RAP but may also impose a decisional burden on bereaved families and healthcare professionals, potentially undermining public trust in medical research [26, 34]. Therefore, it is necessary to reexamine how individual consent for postmortem tissue utilization should be obtained. To address this, the present study investigates how antemortem consent is perceived within the context of interpersonal relationships in Japan, and evaluates public perceptions regarding the necessity of such consent across four distinct methods of postmortem tissue utilization: pathological autopsy, RAP, systematic dissection, and organ transplantation. Our analysis and discussion focus specifically on the tensions between the respect for autonomy and other ethical principles. The findings are expected to inform the development of ethical and legal frameworks, foster social consensus, and support the establishment of institutional guidelines for implementing RAP in Japan. Methods Survey overview This study was conducted as an internet survey targeting registered panelists of Macromill, Inc. in January 2025. Valid responses were obtained from 3,102 participants. The sampling was designed to ensure that the composition ratio of sex, age (20 to 79), and residential area roughly matched Japan’s national population distribution, based on the Statistics Bureau of Japan’s Population Estimates in 2020 [35]. Of the collected data, respondents with extremely short response times across all questions (the bottom 3% of all respondents) were judged to have responded without adequately reading the questions and were thus excluded from the analysis. Since all questions were set as mandatory in this survey, there were no samples with incomplete responses or missing values. Participants were members of the general public who were potential donors or family members for RAP and who consented to the study’s purpose and the handling of personal information beforehand. The study was approved by Kyoto University, Ethics Committee (Approval No. R4748). In the online survey interface, participants were presented with an approximately four-minute video explaining four types of postmortem human tissue utilization, accompanied by a summary table (Fig. 1) and illustrative diagrams (Fig. 2). After viewing the video, participants answered the survey questions. To avoid bias, the actual names of the four methods and their implementation status in Japan were not disclosed. Instead, each method was labeled anonymously as Method A through D. Specifically, “Method A” referred to pathological autopsy, “Method B” to RAP, “Method C” to systematic dissection, and “Method D” to organ transplantation. The survey was developed for this study. The English translation of the full questionnaire is available as a supplementary file [see Additional file 1]. Fig. 1Explanation of each utilization method shown in the explanatory video Explanation of each utilization method shown in the explanatory video Fig. 2Illustrations shown in the explanatory videos for each method Illustrations shown in the explanatory videos for each method Items regarding antemortem and individual consent To ensure content validity, the survey instrument was developed through a multi-step collaborative process. An initial pool of items was drafted by a panel of nine researchers from diverse disciplinary backgrounds, including bioethics (n = 3), clinical medicine (n = 3), and psychology (n = 3), to incorporate multiple professional perspectives. Subsequently, the draft was pilot-tested with several independent researchers to evaluate conceptual clarity and ease of comprehension. Based on their feedback, minor linguistic refinements were made to ensure neutral framing and respondent accessibility before finalizing the instrument. In the actual survey questionnaire [see Additional file 1], the following definition was provided to participants: Definition of “Antemortem Consent and Registration”: “In this survey, ‘antemortem consent and registration’ is defined as an individual—whether a patient or a member of the general public—expressing their intention, at a point when they are capable of careful deliberation and judgment, to allow their body to be used for specific or various medical research and healthcare purposes after their death.” Prior to answering the questionnaire, participants were presented with the potential benefits and concerns associated with antemortem consent. Subsequently, they were asked 11 items regarding their general perceptions of such consent (see Table 2 for the specific items). Subsequently, for each of the four methods, respondents were asked to rate the statement: “In Method X, confirmation of the individual’s will (antemortem consent) is necessary.” Responses were recorded on a six-point Likert scale ranging from 1 = strongly disagree to 6 = strongly agree. In data processing, higher scores indicated stronger agreement with the necessity of obtaining antemortem consent. Results Distribution of responses for general antemortem consent and for each method The number of respondents by demographic attributes is shown in Table 1, and the distribution of responses regarding general antemortem consent is presented in Table 2. For Item 2 (“It allows for the individual’s wishes to be respected”) and Item 4 (“It helps family members in their decision-making process”), approximately 90% of the responses were affirmative (“strongly agree,” “agree,” or “slightly agree”). In contrast, for Item 9 (“It is difficult to refuse a request made by a physician”) and Item 11 (“The wishes of the family are more important than those of the individual regarding postmortem matters”), the proportion of affirmative responses was approximately 50% (55.8% and 51.8%, respectively). Subsequently, the distribution of responses regarding individual consent for each method is presented in Table 3. The proportion of affirmative responses was 71.5% for Method A (pathological autopsy), 86.7% for Method B (RAP), 85.3% for Method C (systematic dissection), and 85.1% for Method D (organ transplantation). Table 1Respondent DemographicsAttributeCategory Frequency PercentageGenderMale153449.5Female156850.5Age Group20s40413.030s47015.240s61019.750s55617.960s52016.870s54217.5 Table 1Respondent DemographicsAttributeCategory Frequency PercentageGenderMale153449.5Female156850.5Age Group20s40413.030s47015.240s61019.750s55617.960s52016.870s54217.5 Respondent Demographics Table 2Frequency Distribution of Responses to “antemortem consent”Strongly agreeAgreeSlightly agreeSlightly disagreeDisagreeStrongly disagree1. Were you aware of "antemortem consent" regarding medical research and healthcare?116 (3.7)457 (14.7)827 (26.7)665 (21.4)539 (17.4)498 (16.1)2. It allows for the individual’s wishes to be respected.602 (19.4)1491 (48.1)760 (24.5)194 (6.3)36 (1.2)19 (0.6)3. It helps build a relationship of trust with physicians.170 (5.5)760 (24.5)1176 (37.9)825 (26.6)120 (3.9)51 (1.6)4. It helps family members in their decision-making process.499 (16.1)1268 (40.9)950 (30.6)292 (9.4)68 (2.2)25 (0.8)5. It may cause psychological distress for patients currently receiving outpatient or inpatient care.170 (5.5)571 (18.4)1121 (36.1)1000 (32.2)181 (5.8)59 (1.9)6. It may worsen the relationship with physicians.64 (2.1)189 (6.1)443 (14.3)1782 (57.4)478 (15.4)146 (4.7)7. It may worsen relationships with family members.53 (1.7)158 (5.1)496 (16.0)1716 (55.3)496 (16.0)183 (5.9)8. I do not want to discuss postmortem matters while still alive.105 (3.4)274 (8.8)719 (23.2)1113 (35.9)530 (17.1)361 (11.6)9. It is difficult to refuse a request made by a physician.145 (4.7)513 (16.5)1073 (34.6)912 (29.4)320 (10.3)139 (4.5)10. Being provided with such explanations in a hospital makes me feel that death is near.260 (8.4)731 (23.6)1127 (36.3)682 (22.0)212 (6.8)90 (2.9)11. The wishes of the family are more important than those of the individual regarding postmortem matters.205 (6.6)503 (16.2)900 (29.0)984 (31.7)321 (10.3)189 (6.1)Note. Values in parentheses indicate percentages (%). For Item 1, the response distribution ranges from "Extremely well aware" to "Not aware at all." Table 2Frequency Distribution of Responses to “antemortem consent”Strongly agreeAgreeSlightly agreeSlightly disagreeDisagreeStrongly disagree1. Were you aware of "antemortem consent" regarding medical research and healthcare?116 (3.7)457 (14.7)827 (26.7)665 (21.4)539 (17.4)498 (16.1)2. It allows for the individual’s wishes to be respected.602 (19.4)1491 (48.1)760 (24.5)194 (6.3)36 (1.2)19 (0.6)3. It helps build a relationship of trust with physicians.170 (5.5)760 (24.5)1176 (37.9)825 (26.6)120 (3.9)51 (1.6)4. It helps family members in their decision-making process.499 (16.1)1268 (40.9)950 (30.6)292 (9.4)68 (2.2)25 (0.8)5. It may cause psychological distress for patients currently receiving outpatient or inpatient care.170 (5.5)571 (18.4)1121 (36.1)1000 (32.2)181 (5.8)59 (1.9)6. It may worsen the relationship with physicians.64 (2.1)189 (6.1)443 (14.3)1782 (57.4)478 (15.4)146 (4.7)7. It may worsen relationships with family members.53 (1.7)158 (5.1)496 (16.0)1716 (55.3)496 (16.0)183 (5.9)8. I do not want to discuss postmortem matters while still alive.105 (3.4)274 (8.8)719 (23.2)1113 (35.9)530 (17.1)361 (11.6)9. It is difficult to refuse a request made by a physician.145 (4.7)513 (16.5)1073 (34.6)912 (29.4)320 (10.3)139 (4.5)10. Being provided with such explanations in a hospital makes me feel that death is near.260 (8.4)731 (23.6)1127 (36.3)682 (22.0)212 (6.8)90 (2.9)11. The wishes of the family are more important than those of the individual regarding postmortem matters.205 (6.6)503 (16.2)900 (29.0)984 (31.7)321 (10.3)189 (6.1)Note. Values in parentheses indicate percentages (%). For Item 1, the response distribution ranges from "Extremely well aware" to "Not aware at all." Frequency Distribution of Responses to “antemortem consent” Note. Values in parentheses indicate percentages (%). For Item 1, the response distribution ranges from "Extremely well aware" to "Not aware at all." Table 3Frequency Distribution of Responses to “In Method X, confirmation of the individual’s will (antemortem consent) is necessary”Method A(Pathological Autopsy)Method B(RAP)Method C(Systematic Dissection)Method D(Organ Transplantation)Degree(%)Degree(%)Degree(%)Degree(%)Strongly agree398(12.8)683(22.0)968(31.2)916(29.5)Agree873(28.1)1181(38.1)994(32.0)1040(33.5)Slightly agree950(30.6)826(26.6)687(22.1)685(22.1)Slightly disagree589(19.0)285(9.2)288(9.3)306(9.9)Disagree218(7.0)83(2.7)115(3.7)110(3.5)Strongly disagree74(2.4)44(1.4)50(1.6)45(1.5) Table 3Frequency Distribution of Responses to “In Method X, confirmation of the individual’s will (antemortem consent) is necessary”Method A(Pathological Autopsy)Method B(RAP)Method C(Systematic Dissection)Method D(Organ Transplantation)Degree(%)Degree(%)Degree(%)Degree(%)Strongly agree398(12.8)683(22.0)968(31.2)916(29.5)Agree873(28.1)1181(38.1)994(32.0)1040(33.5)Slightly agree950(30.6)826(26.6)687(22.1)685(22.1)Slightly disagree589(19.0)285(9.2)288(9.3)306(9.9)Disagree218(7.0)83(2.7)115(3.7)110(3.5)Strongly disagree74(2.4)44(1.4)50(1.6)45(1.5) Frequency Distribution of Responses to “In Method X, confirmation of the individual’s will (antemortem consent) is necessary” Analysis of demographic differences in antemortem consent Table 4 shows the mean scores for the antemortem consent item by gender and age group. Regarding the assumption of normality, the skewness (− 0.90 to − 0.39) and kurtosis (− 0.29 to 0.71) for all four dependent variables were within the widely accepted criteria in psychometrics and survey research. Therefore, we determined that the application of parametric methods was appropriate. Table 4Means for the antemortem consent item by gender and age groupMethod A (Pathological Autopsy)Method B (RAP)Method C (Systematic Dissection)Method D (Organ Transplantation)Male4.11 (1.21)4.50 (1.12)4.54 (1.21)4.52 (1.20)Female4.16 (1.21)4.76 (1.04)4.91 (1.15)4.90 (1.12)20s4.08 (1.31)4.50 (1.29)4.39 (1.39)4.44 (1.34)30s3.95 (1.28)4.48 (1.19)4.54 (1.34)4.52 (1.29)40s4.12 (1.19)4.68 (1.10)4.76 (1.22)4.70 (1.20)50s4.21 (1.18)4.65 (1.02)4.79 (1.14)4.76 (1.12)60s4.19 (1.14)4.70 (0.99)4.90 (1.04)4.85 (1.07)70s4.23 (1.17)4.73 (0.95)4.88 (0.99)4.92 (0.98)Overall4.14 (1.21)4.63 (1.09)4.73 (1.19)4.71 (1.17)( ) indicates standard deviation Table 4Means for the antemortem consent item by gender and age groupMethod A (Pathological Autopsy)Method B (RAP)Method C (Systematic Dissection)Method D (Organ Transplantation)Male4.11 (1.21)4.50 (1.12)4.54 (1.21)4.52 (1.20)Female4.16 (1.21)4.76 (1.04)4.91 (1.15)4.90 (1.12)20s4.08 (1.31)4.50 (1.29)4.39 (1.39)4.44 (1.34)30s3.95 (1.28)4.48 (1.19)4.54 (1.34)4.52 (1.29)40s4.12 (1.19)4.68 (1.10)4.76 (1.22)4.70 (1.20)50s4.21 (1.18)4.65 (1.02)4.79 (1.14)4.76 (1.12)60s4.19 (1.14)4.70 (0.99)4.90 (1.04)4.85 (1.07)70s4.23 (1.17)4.73 (0.95)4.88 (0.99)4.92 (0.98)Overall4.14 (1.21)4.63 (1.09)4.73 (1.19)4.71 (1.17)( ) indicates standard deviation Means for the antemortem consent item by gender and age group ( ) indicates standard deviation To examine whether mean scores differed by method and demographic variables, a three-way mixed-design ANOVA was conducted, with Method (within-subject factor) and Gender and Age Group (between-subject factors) as independent variables (Table 5). Mauchly’s test indicated that the assumption of sphericity had been violated (χ2 (5) = 1211.66, p < .001), and therefore, degrees of freedom were corrected using Greenhouse-Geisser estimates (ε = 0.779). The second-order interaction was not significant. However, both the Method × Gender and Method × Age Group interactions were significant, although the effect sizes were very small (respectively, F (2.34, 7218.91) = 28.53, p < .001, partial η² = 0.01; F (11.68, 7218.91) = 3.15, p < .001, partial η² = 0.01). The main effect of Method was significant, showing a medium effect size (F (2.34, 7218.91) = 354.90, p < .001, partial η² = 0.10). Table 5Mixed design ANOVA results for the need for the antemortem consent (within: Method)Factor df F η p 2 Method2.34354.90 ***0.10Method × Gender2.3428.53 ***0.01Method × Age Group11.683.15 ***0.01Method × Gender × Age Group11.680.85 n.s.0.00*** p < .001 Table 5Mixed design ANOVA results for the need for the antemortem consent (within: Method)Factor df F η p 2 Method2.34354.90 ***0.10Method × Gender2.3428.53 ***0.01Method × Age Group11.683.15 ***0.01Method × Gender × Age Group11.680.85 n.s.0.00*** p < .001 Mixed design ANOVA results for the need for the antemortem consent (within: Method) *** p < .001 Subsequently, post hoc multiple comparisons were conducted for the Method × Gender and Method × Age Group interactions, as well as for the main effect of Method. The mean plots for each factor are shown in Figs. 3, 4 and 5. For the Method × Gender interaction, both men and women rated pathological autopsy significantly lower than RAP, systematic dissection, and organ transplantation, with small to medium effect sizes (dz = 0.32 − 0.62; Table 6). Among women, RAP was rated significantly lower than systematic dissection and organ transplantation; however, the effect sizes were below 0.20, indicating minimal practical differences. Regarding RAP, which is the main focus of this study, men rated it significantly lower than women (mean difference = − 0.26, SE = 0.04, p < .001, d = 0.24), suggesting a small gender effect. Fig. 3Means for the need for antemortem consent by Method and Gender Means for the need for antemortem consent by Method and Gender Fig. 4Means for the need for antemortem consent by Method and Age Group Means for the need for antemortem consent by Method and Age Group Fig. 5Means for the need for antemortem consent by Method Means for the need for antemortem consent by Method Table 6Multiple Comparison by Gender × Method for the need for antemortem consent (Bonferroni method) Mean Difference95% Confidence IntervalEffect Size(I) factor(J) factor (I-J)LowerUpper dz MaleMethod AMethod B-0.49 ***-0.47-0.300.32Method C-0.58 ***-0.51-0.320.36Method D-0.57 ***-0.49-0.31034Method BMethod C-0.09-0.100.030.04Method D-0.07-0.080.050.02Method CMethod D0.01-0.040.08-0.02FemaleMethod AMethod B-0.60 ***-0.69-0.520.50Method C-0.75 ***-0.84-0.650.62Method D-0.74 ***-0.83-0.640.62Method BMethod C-0.14 ***-0.21-0.080.14Method D-0.13 ***-0.20-0.070.13Method CMethod D0.01-0.050.07-0.01***p < .001, “Method A” referred to pathological autopsy, “Method B” to RAP, “Method C” to systematic dissection, and “Method D” to organ transplantation Table 6Multiple Comparison by Gender × Method for the need for antemortem consent (Bonferroni method) Mean Difference95% Confidence IntervalEffect Size(I) factor(J) factor (I-J)LowerUpper dz MaleMethod AMethod B-0.49 ***-0.47-0.300.32Method C-0.58 ***-0.51-0.320.36Method D-0.57 ***-0.49-0.31034Method BMethod C-0.09-0.100.030.04Method D-0.07-0.080.050.02Method CMethod D0.01-0.040.08-0.02FemaleMethod AMethod B-0.60 ***-0.69-0.520.50Method C-0.75 ***-0.84-0.650.62Method D-0.74 ***-0.83-0.640.62Method BMethod C-0.14 ***-0.21-0.080.14Method D-0.13 ***-0.20-0.070.13Method CMethod D0.01-0.050.07-0.01***p < .001, “Method A” referred to pathological autopsy, “Method B” to RAP, “Method C” to systematic dissection, and “Method D” to organ transplantation Multiple Comparison by Gender × Method for the need for antemortem consent (Bonferroni method) ***p < .001, “Method A” referred to pathological autopsy, “Method B” to RAP, “Method C” to systematic dissection, and “Method D” to organ transplantation In the multiple comparisons for the Method × Age Group interaction, pathological autopsy was rated significantly lower than RAP, systematic dissection, and organ transplantation across all age groups, with effect sizes ranging from none to medium (dz = 0.17 − 0.63; Table 7). Among participants in their 50s to 70s, RAP was rated significantly lower than systematic dissection and organ transplantation, but the effect sizes were small (dz = 0.11 − 0.20). Additionally, participants in their 20s and 30s tended to show lower scores across all methods (Fig. 4). For RAP specifically, participants in their 20s scored significantly lower than those in their 70s (mean difference = − 0.23, SE = 0.07, p < .05, d = 0.21). Participants in their 30s also scored significantly lower than those in their 40s, 60s, and 70s (mean differences = − 0.20, − 0.22, and − 0.26; SE = 0.07; ps < 0.05 − 0.01; ds = 0.18 − 0.24), indicating small effects. Table 7Multiple Comparison by Age Group × Method for the need for antemortem consent (Bonferroni Method) Mean Differences95% Confidence IntervalEffect Size(I) factor(J) factor(I-J)LowerUpper dz 20sMethod AMethod B-0.426 ***-0.59-0.260.32Method C-0.32 ***-0.50-0.140.24Method D-0.36 ***-0.54-0.180.17Method BMethod C0.11-0.020.23-0.09Method D0.06-0.060.19-0.05Method CMethod D-0.04-0.160.070.0330sMethod AMethod B-0.53 ***-0.68-0.380.41Method C-0.59 ***-0.76-0.420.46Method D-0.57 ***-0.73-0.400.44Method BMethod C-0.06-0.180.050.05Method D-0.04-0.150.080.03Method CMethod D0.02-0.080.13-0.0240sMethod AMethod B-0.56 ***-0.69-0.420.47Method C-0.64 ***-0.79-0.490.54Method D0.58 ***-0.73-0.440.49Method BMethod C-0.08-0.180.020.07Method D-0.03-0.130.070.02Method CMethod D0.05-0.040.15-0.0550sMethod AMethod B-0.44 ***-0.58-0.310.38Method C-0.59 ***-0.74-0.430.50Method D-0.55 ***-0.70-0.400.47Method BMethod C-0.14 **-0.25-0.030.14Method D-0.11 *-0.210.000.11Method CMethod D0.03-0.060.13-0.0360sMethod AMethod B-0.51 ***-0.65-0.370.45Method C-0.71 ***-0.87-0.550.63Method D-0.66 ***-0.82-0.500.58Method BMethod C-0.20 ***-0.31-0.090.20Method D-0.15 **-0.26-0.040.15Method CMethod D0.05-0.050.15-0.0570sMethod AMethod B-0.49 ***-0.63-0.350.43Method C-0.64 ***-0.80-0.480.56Method D-0.68 ***-0.83-0.520.59Method BMethod C-0.15 **-0.26-0.040.16Method D-0.19 ***-0.29-0.080.20Method CMethod D-0.04-0.130.060.04***p < .001, **p < .01, *p < .05, “Method A” referred to pathological autopsy, “Method B” to RAP, “Method C” to systematic dissection, and “Method D” to organ transplantation Table 7Multiple Comparison by Age Group × Method for the need for antemortem consent (Bonferroni Method) Mean Differences95% Confidence IntervalEffect Size(I) factor(J) factor(I-J)LowerUpper dz 20sMethod AMethod B-0.426 ***-0.59-0.260.32Method C-0.32 ***-0.50-0.140.24Method D-0.36 ***-0.54-0.180.17Method BMethod C0.11-0.020.23-0.09Method D0.06-0.060.19-0.05Method CMethod D-0.04-0.160.070.0330sMethod AMethod B-0.53 ***-0.68-0.380.41Method C-0.59 ***-0.76-0.420.46Method D-0.57 ***-0.73-0.400.44Method BMethod C-0.06-0.180.050.05Method D-0.04-0.150.080.03Method CMethod D0.02-0.080.13-0.0240sMethod AMethod B-0.56 ***-0.69-0.420.47Method C-0.64 ***-0.79-0.490.54Method D0.58 ***-0.73-0.440.49Method BMethod C-0.08-0.180.020.07Method D-0.03-0.130.070.02Method CMethod D0.05-0.040.15-0.0550sMethod AMethod B-0.44 ***-0.58-0.310.38Method C-0.59 ***-0.74-0.430.50Method D-0.55 ***-0.70-0.400.47Method BMethod C-0.14 **-0.25-0.030.14Method D-0.11 *-0.210.000.11Method CMethod D0.03-0.060.13-0.0360sMethod AMethod B-0.51 ***-0.65-0.370.45Method C-0.71 ***-0.87-0.550.63Method D-0.66 ***-0.82-0.500.58Method BMethod C-0.20 ***-0.31-0.090.20Method D-0.15 **-0.26-0.040.15Method CMethod D0.05-0.050.15-0.0570sMethod AMethod B-0.49 ***-0.63-0.350.43Method C-0.64 ***-0.80-0.480.56Method D-0.68 ***-0.83-0.520.59Method BMethod C-0.15 **-0.26-0.040.16Method D-0.19 ***-0.29-0.080.20Method CMethod D-0.04-0.130.060.04***p < .001, **p < .01, *p < .05, “Method A” referred to pathological autopsy, “Method B” to RAP, “Method C” to systematic dissection, and “Method D” to organ transplantation Multiple Comparison by Age Group × Method for the need for antemortem consent (Bonferroni Method) ***p < .001, **p < .01, *p < .05, “Method A” referred to pathological autopsy, “Method B” to RAP, “Method C” to systematic dissection, and “Method D” to organ transplantation Results of the overall multiple comparisons among the Methods indicated that pathological autopsy was rated significantly lower than RAP, systematic dissection, and organ transplantation, with small to medium effect sizes (dz = 0.41 − 0.49; Table 8). RAP was also rated significantly lower than systematic dissection and organ transplantation, but the effect sizes were below 0.10, suggesting negligible practical differences. Table 8Multiple Comparison by Method for the need for antemortem consent (Bonferroni Method) Mean Differences95% Confidence IntervalEffect Size(I) factor(J) factor(I-J)LowerUpper dz Method AMethod B-0.49 ***-0.55-0.430.41Method C-0.58 ***-0.65-0.510.49Method D-0.57 ***-0.63-0.500.48Method BMethod C-0.09 ***-0.13-0.040.09Method D-0.07 ***-0.12-0.030.07Method CMethod D0.01-0.030.05-0.01***p < .001, “Method A” referred to pathological autopsy, “Method B” to RAP, “Method C” to systematic dissection, and “Method D” to organ transplantation Table 8Multiple Comparison by Method for the need for antemortem consent (Bonferroni Method) Mean Differences95% Confidence IntervalEffect Size(I) factor(J) factor(I-J)LowerUpper dz Method AMethod B-0.49 ***-0.55-0.430.41Method C-0.58 ***-0.65-0.510.49Method D-0.57 ***-0.63-0.500.48Method BMethod C-0.09 ***-0.13-0.040.09Method D-0.07 ***-0.12-0.030.07Method CMethod D0.01-0.030.05-0.01***p < .001, “Method A” referred to pathological autopsy, “Method B” to RAP, “Method C” to systematic dissection, and “Method D” to organ transplantation Multiple Comparison by Method for the need for antemortem consent (Bonferroni Method) ***p < .001, “Method A” referred to pathological autopsy, “Method B” to RAP, “Method C” to systematic dissection, and “Method D” to organ transplantation Discussion This study conducted a nationwide survey in Japan to examine perceptions of the necessity of antemortem consent for four types of postmortem human tissue utilization. Differences by utilization method, gender, and age group were identified, as well as gender and age differences specifically within the RAP. The results showed that more than 70% of respondents agreed that antemortem consent is necessary for all types of postmortem tissue utilization. In particular, affirmative responses exceeded 85% for RAP, systematic dissection, and organ transplantation. These findings suggest that, regardless of the intended purpose of tissue utilization, a widely shared social recognition exists in Japan that “clear expression of the individual’s will is essential for postmortem body utilization.” Effect sizes indicated that differences in perceptions of antemortem consent were larger across utilization methods than across demographic attributes. Therefore, discussions involving the broad public, who are potential donors, are necessary regarding consent for postmortem tissue utilization. The relatively lower scores among younger respondents may reflect fewer opportunities for social exposure to end-of-life decision-making, limited experiences related to death and dying, and insufficient information regarding expressing wishes for end-of-life care [36]. Currently, awareness campaigns for postmortem tissue utilization primarily focus on organ transplantation. Expanding these campaigns to include other utilization methods and raising awareness among the general public, including younger generations, is expected to foster greater societal consensus and enhance trust in medical research. Although overall levels of agreement were high, pathological autopsy received significantly lower mean scores than the other three methods. This may reflect the institutional and historical context in Japan, where, under the current Act on Autopsy and Preservation of the Body, pathological autopsies can be conducted with family consent alone, without requiring the decedent’s antemortem consent. The influence of the explanatory text used in the survey — distinguishing whether antemortem registration is expected — may also have affected responses. Nevertheless, it is noteworthy that over 70% of respondents still agreed that antemortem consent should be required for pathological autopsy. This finding highlights a clear gap between Japan’s current legal framework, which prioritizes family consent, and public ethical awareness favoring individual autonomy. Furthermore, it is noteworthy that no significant differences were observed among RAP, systematic dissection, and organ transplantation. This suggests that the moral intuitions of the Japanese public align with the normative position that RAP—given its ethical characteristics, such as (1) temporal constraints, (2) minimal direct benefit to the donor, and (3) a focus on the principle of beneficence toward society—requires a level of consent more comparable to systematic dissection or organ transplantation than to conventional autopsies. Notably, although the procedural steps following a patient’s death are similar for both pathological autopsy and RAP, our results reaffirm that public intuitions regarding the underlying ethical challenges of RAP differ distinctly from those associated with pathological autopsy. Within the framework of empirical bioethics, the actual moral intuitions held by the public are positioned as a crucial starting point for adapting abstract ethical principles to real-world contexts [37]. In the present study, these public moral intuitions are treated not as self-contained moral justifications, but as indicators of social legitimacy that necessitate critical normative interpretation. From this perspective, the intuitions demonstrated by the public in this survey provide the normative grounds for constructing a consent governance framework for RAP in Japan. Compared to other methods of postmortem tissue utilization, RAP is characterized by the psychological burden on bereaved families due to temporal constraints, the lack of direct benefits to the donor or their family, and its grounding in the principle of beneficence directed toward society. These distinctive features strengthen the normative requirement for explicit antemortem consent from the donor. Indeed, there is a global trend recommending individual consent for RAP due to the unique nature of its research objectives [21, 24]. Our findings suggest that in Japan, there is potential for broad public support for operational models based on antemortem consent for postmortem tissue utilization, including RAP. This underscores the necessity of considering institutional designs and public awareness initiatives centered on individual consent to ensure that RAP is implemented in alignment with international ethical standards. Furthermore, regarding antemortem consent in medical care and research, approximately 90% of respondents in this study perceived it positively, suggesting that such consent is highly necessary for respecting individual wishes and assisting family decision-making. At the same time, however, more than half of the respondents indicated that it would be difficult to refuse a request if made by a physician. This result suggests that the asymmetrical power relationship between the attending physician and the patient in clinical settings [17] could potentially hinder free decision-making regarding postmortem tissue donation. From the perspective of the principle of respect for autonomy, establishing a system that ensures a clear separation of clinical and research teams [12–14] constitutes an indispensable governance structure for ensuring both the operational efficacy and ethical legitimacy of RAP in Japan. To make the explicit opt-in model truly effective within RAP, it is crucial to move beyond the mere act of signing a consent form; instead, a robust framework must be established to protect the voluntariness and continuity of the donor’s decision-making process. Notably, while respondents emphasized respect for individual wishes, more than half also stated that “the wishes of the family are more important than those of the individual regarding postmortem matters.” This finding does not necessarily imply a conflict between respect for patient autonomy and the interests of the family. Rather, it likely reflects “relational autonomy”—a concept prevalent in Asian cultures, including Japan, where self-determination is constructed within the context of family relationships, in contrast to the Western concept of autonomy that views the individual as an isolated entity [15, 38]. In this sense, the emphasis on family wishes can be interpreted not as a rejection of individual autonomy, but as a reflection of a Japanese form of autonomy embedded within these relationships. Therefore, a consent model for RAP in Japan should be based on explicit individual consent (opt-in) while incorporating a framework of “supported decision-making” [18] that includes family members and close relatives, which would likely ensure higher cultural compatibility. This process is also recommended from the perspective of non-maleficence, as it aims to minimize the psychological burden on bereaved families—a challenge inherent to the rapid nature of RAP. We contend that securing consent through a continuous process of dialogue with family members starting from the antemortem stage is an effective approach to resolving the tension between respect for autonomy and the psychological non-maleficence of the family. In light of the preceding discussion, our analysis supports a normative position that prioritizes explicit antemortem consent as a primary ethical requirement for RAP in Japan. While relational autonomy emphasizes the significance of family involvement in decision-making, such involvement should be understood as complementary rather than substitutive. In cases where the individual’s wishes are unclear, family input should be regarded as merely supportive and interpretative; it cannot serve as a substitute for the individual’s own autonomy. This stance seeks to harmonize the principle of respect for autonomy with the socio-cultural reality of relational decision-making in Japan. Analysis focusing on gender and age differences regarding the necessity of antemortem consent for RAP revealed that women scored higher than men, while those in their 20s and 30s scored relatively lower, with those in their 70s scoring the highest. Previous international studies have also reported gender and age differences in attitudes and behaviors regarding body and organ donation after death. For instance, women tend to exhibit stronger altruistic and prosocial motivations [39, 40] and greater sensitivity toward postmortem bodily treatment [41]. Some studies have also shown higher donor registration rates among women and older individuals in certain regions [39, 42, 43]. The present findings are consistent with these reports: older adults may perceive death more realistically as part of their life stage, a pattern observed across countries. Additionally, in Japan, the proportion of female physicians is 23.6% [44], which may influence gendered ethical perspectives, with women placing greater emphasis on respecting individual will. Women and older adults may thus consider not only research outcomes but also the ethical integrity of the consent process itself as essential. These findings underscore the importance of developing institutional systems and cultural foundations that integrate respect for individual autonomy into the practice and governance of postmortem tissue utilization. Based on the preceding results and discussion, it can be argued that Japan’s conventional consent model for pathological autopsies—while securing bereavement consent—has often failed to sufficiently safeguard individual intent, prioritizing instead the principle of beneficence through the acquisition of medical knowledge. In the case of RAP, this focus on beneficence is even more pronounced, as the research aims for a broader scope of medical advancement from which the donors and their families derive little direct benefit [20, 22, 23]. Consequently, the donor’s decision-making is strongly motivated by the maximization of social beneficence rather than immediate familial gain, making the proactive expression of the individual’s voluntary intent indispensable. Furthermore, given the individual variations across demographic attributes observed in our results, we contend that neither presumed consent (opt-out) nor implicit consent models should be recommended for RAP [12]. Family authorization should be positioned strictly as a complementary, proxy approval, applicable only in cases where the donor’s intent to participate was clear during their lifetime but lacked explicit written documentation. Securing explicit written consent from the individual ensures respect for posthumous autonomy [13]. Such autonomy is understood as a continuation of choices made during life; in a society where posthumous autonomy is respected, individuals are empowered to make forward-looking choices, thereby substantively expanding their autonomy while living [45]. From this perspective, in programs like RAP—which possess strong altruistic and pro-social dimensions—explicit and deliberative antemortem consent serves as a vital ethical foundation for research practices rooted in the principle of beneficence. The findings of this study call for further discourse on the development of ethical and legal frameworks in Japan that prioritize antemortem consent. Such frameworks would facilitate the smooth implementation of RAP and contribute to maintaining public trust in medical research. From an international perspective, ethical controversies such as the use of Henrietta Lacks’ cancer cells without her consent [46] and unauthorized body donations in certain African regions [47] have underscored the importance of explicit antemortem individual consent. Moving forward, there is a need in Japan to promote public awareness regarding postmortem tissue utilization and to establish systematic procedures predicated on obtaining antemortem consent. In particular, when introducing RAP, it will be essential to foster discourse toward developing guidelines that are culturally compatible with the Japanese context. These guidelines should be centered on the provider’s explicit declaration of intent, such as through written consent, while drawing on the consent model used in systematic dissection [48]. Limitations Although this study involved a large-scale national survey, it was conducted online and therefore limited to individuals with internet access, potentially introducing sampling bias. Additionally, participants’ levels of comprehension regarding the explanatory materials presented in the survey may have varied, which should be considered when interpreting the findings. Conclusions This study is the first to empirically examine, using a nationwide sample, public perceptions in Japan regarding antemortem consent for various forms of postmortem tissue utilization, including the Rapid Autopsy Program (RAP). More than 70% of respondents agreed that antemortem consent is necessary for pathological autopsy, and over 85% expressed the same view for uses related to research and education (RAP, systematic dissection, and organ transplantation). These findings reveal a marked discrepancy between Japan’s current system - centered on family consent - and the ethical awareness of the general public, which emphasizes respect for individual will. For RAP in particular, women and older adults placed greater importance on antemortem consent, indicating gender- and age-related differences in ethical sensitivity and self-determination. These trends are consistent with international reports on gender and age differences regarding systematic dissection and organ donation. Furthermore, while many respondents recognized the benefits of respecting individual wishes through antemortem consent, the results also highlighted the “relational autonomy” aspect, where individuals find it difficult to refuse requests from attending physicians in clinical settings and place high value on family intentions. These findings suggest that when considering the ethical and legal frameworks for postmortem tissue utilization, including RAP, in Japan, it is crucial to incorporate operational considerations such as supported decision-making involving the family and the clear separation of clinical and research teams, rather than simply prioritizing individual autonomy in isolation. This study provides a scientific foundation to facilitate academic discourse toward developing highly transparent consent models and guidelines that are culturally compatible with the Japanese context. Supplementary Information Additional file 1: Title of data: English version of the survey questionnaire Description of data: This file contains the complete English translation of the survey instrument used in this study, including questions regarding public perceptions of antemortem informed consent for RAP and comparisons with other postmortem tissue utilization methods. Additional file 1: Title of data: English version of the survey questionnaire Description of data: This file contains the complete English translation of the survey instrument used in this study, including questions regarding public perceptions of antemortem informed consent for RAP and comparisons with other postmortem tissue utilization methods.